Medtronic (MDT) executive Smith sold 30,000 shares for $3.06M at an average $101.95
Insider transactions reported
Gregory L Smith (EVP Global Ops & Supply Chain at Medtronic plc., MDT) reported that they sold 30,000 shares for $3.06M at an average $101.95 on Nov 19, 2025. After these transactions the filing shows 46,016 shares held directly.
- Reporting person
- Smith Gregory L
- Role
- EVP Global Ops & Supply Chain
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 19, 2025 | Open-market sale (S) | Ordinary Shares1 | -30,000 | avg $101.95 | $3.06M | 46,016 direct |
Holdings before and after
- Ordinary Shares: 76,016 to 46,016 direct
Footnotes from the filing
- 1. Includes 323 shares acquired through dividend reinvestment and 96 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Smith report in this MDT Form 4?
Gregory L Smith (EVP Global Ops & Supply Chain at Medtronic plc., MDT) reported that they sold 30,000 shares for $3.06M at an average $101.95 on Nov 19, 2025. After these transactions the filing shows 46,016 shares held directly.
How many MDT shares does Smith hold after this filing?
The filing shows 46,016 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this MDT insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for MDT
Across the 5 sessions after earlier MDT headlines, the stock closed higher 2 times and lower 3 times, with a median move of 0.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | MDT | SPY |
|---|---|---|---|
| Nov 19, 2025 | Medtronic upgraded by Goldman with a new price target | -0.5% | +0.4% |
| Nov 18, 2025 | Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum | +4.7% | -0.8% |
| Nov 6, 2025 | Medtronic to announce financial results for its second quarter of fiscal year 2026 | -0.4% | -1.1% |
| Oct 29, 2025 | U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system | -1.6% | +0.0% |
| Oct 27, 2025 | Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions | +0.5% | +1.2% |
Earlier insider filings at MDT
- Sep 5, 2025EVP & President Cardiovascular Kiil Harry Skip sold $788,048 worth of Ordinary Shares (8,605 units at $91.58), decreasing direct ownership by 19% to 35,615 units (SEC Form 4)
- Aug 25, 2025Director Jellison William R bought $462,750 worth of Ordinary Shares (5,000 units at $92.55) (SEC Form 4)
- Aug 21, 2025EVP, Pres MedSurg and Americas Marinaro Michael covered exercise/tax liability with 1,052 units of Ordinary Shares, decreasing direct ownership by 2% to 51,939 units (SEC Form 4)
- Aug 4, 2025SVP, Chief HR Officer Walter Matthew R. exercised 3,142 units of Ordinary Shares at a strike of $23.91 and covered exercise/tax liability with 1,910 units of Ordinary Shares, increasing direct ownership by 4% to 31,857 units (SEC Form 4)
- Aug 4, 2025EVP & Pres Neuroscience Wall Brett A. covered exercise/tax liability with 11,594 units of Ordinary Shares and converted options into 15,249 units of Ordinary Shares, increasing direct ownership by 7% to 54,937 units (SEC Form 4)
Keep researching MDT
- MDT insider tradesEvery buy and sale reported by Medtronic plc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- MDT financial statementsRevenue, profit, cash flow and balance sheet from Medtronic plc.'s SEC filings.
- MDT dividend historyDividends Medtronic plc. has declared, with ex-dates and payment dates.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
Follow MDT and get a push notification the moment its next story breaks.